| ¿µ¹® | venereal disease, sexually transmitted diseases | ÇÑ±Û | ¼ºº´ |
|---|---|---|---|
| ¼³¸í | º¸ÆíÀûÀ¸·Î ¼º±³ ¶Ç´Â ¼º±âÁ¢ÃË¿¡ ÀÇÇØ °É¸®´Â Á¢ÃË Àü¿°º´À¸·Î ¸Åµ¶, ÀÓÁú, ¹«¸¥±Ë¾ç, »ô±¼À°¾ÆÁ¾ µîÀ» ¸»ÇÑ´Ù. Ä¡·á´Â ¿øÀαտ¡ µû¸¥ ÀûÀýÇÑ Ç×»ý¿ä¹ýÀÌ´Ù. |
||
| ¿µ¹® | VDRL(venereal disease research laboratory) | ÇÑ±Û | ¼ºº´ ¿¬±¸½ÇÇè½Ç |
|---|---|---|---|
| ¼³¸í | ¸Åµ¶±ÕÀÇ reagin¿¡ ´ëÇÑ Ç×ü. ¸Åµ¶ÀÇ ¼±º°°Ë»ç·Î »ç¿ëµÇ¸ç ¸Åµ¶ Ä¡·á¿¡ ´ëÇÑ ¹ÝÀÀ ¿©ºÎ¿Í Ä¡·áÈ¿°ú ÆÇÁ¤¿¡µµ »ç¿ëµÈ´Ù. ¸Åµ¶¿Ü¿¡µµ Àü½Å¼ºÈ«¹Ý¼º³¶Ã¢, ·ù¸¶Æ¼½º°üÀý¿° µî¿¡¼µµ ¾ç¼ºÀ¸·Î ³ªÅ¸³¯ ¼ö ÀÖ´Ù. |
||
| ¿µ¹® | hemolytic disease of newborn | ÇÑ±Û | ½Å»ý¾Æ¿ëÇ÷º´ |
|---|---|---|---|
| ¼³¸í | ½Å»ý¾Æ¿¡¼ ÀûÇ÷±¸°¡ ºñÁ¤»óÀûÀ¸·Î ¸¹ÀÌ ÆÄ±«µÇ´Â º´À¸·Î žÆÀû¸ð±¸Áõ(erythroblastosis fetalis)¿Í °°Àº ¶æÀ¸·Î ¾²ÀδÙ. À̰ÍÀº ¾î¸Ó´Ï¿¡°Ô¼ »ý»êµÈ ½Å»ý¾Æ³ª žÆÀÇ ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü°¡ ŹÝÀ» °Ç³Ê¿Í¼ žÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÇÏ¿©¼ »ý±â´Â ¿ëÇ÷¼ººóÇ÷À» À̸£´Â ¸». Áï ½Å»ý¾Æ³ª žÆÀÇ ÀûÇ÷±¸ÀÇ Ç×ü°¡ ¾î¸Ó´ÏÀÇ ¸ö¿¡¼ »ý»êÀÌ µÇ°í À̰ÍÀÌ Å¹ÝÀ» ÅëÇØ¼ žƿ¡°Ô ³Ñ¾î°¡¼ žÆÀÇ ÀûÇ÷±¸¿Í °áÇÕÀ» Çϰí ÀÌ Ç×ü¿Í °áÇÕÇÑ ÀûÇ÷±¸´Â ÆÄ±«°¡ µÇ¾î¼ ºóÇ÷ÀÌ »ý±ä °ÍÀ» žÆÀû¸ð±¸ÁõÀ̶ó°í ÇÑ´Ù. À̰ÍÀº Rh Àû¸ð±¸Áõ(Rh erythroblastosis)¿Í ABO Àû¸ð±¸Áõ(ABO erythroblastosis)·Î ³ª´ ¼ö°¡ ÀÖ´Ù. |
||
| ¿µ¹® | coronary artery disease | ÇÑ±Û | ½ÉÀ嵿¸Æº´ |
|---|---|---|---|
| ¼³¸í | ½ÉÀ嵿¸ÆÀ̶õ ½ÉÀå¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â µ¿¸ÆÀ» ¸»ÇÑ´Ù. ½ÉÀåµµ ´Ù¸¥ ±ÙÀ°°ú ¸¶Âù°¡Áö·Î Ç÷¾×À» °ø±Þ¹Þ¾Æ¾ß ¼öÃàÀ» ÇÒ ¼ö°¡ ÀÖ´Â ±â°üÀ¸·Î ½ÉÀåÀÇ Ç÷¾×À» °ø±ÞÇÏ´Â µ¿¸ÆÀ» ½ÉÀ嵿¸ÆÀ̶ó°í ÇÑ´Ù. ½ÉÀ嵿¸Æº´À̶õ ½ÉÀ嵿¸ÆÀÇ ³»°æÀÌ Á¼¾ÆÁ®¼ »ý±â´Â ÁúȯÀ¸·Î ÇãÇ÷½ÉÀ庴(ischemic heart disease)À̶ó°íµµ ºÒ¸°´Ù. °ü»óµ¿¸ÆÀÌ Á¼¾ÆÁú °æ¿ì¿¡´Â ½ÉÀåÀ¸·Î °¡´Â Ç÷¾×ÀÇ ¾çÀÌ Àû¾îÁ®¼ ½ÉÀå¿¡ ÃæºÐÇÑ Ç÷¾×ÀÌ °ø±ÞÀÌ µÇÁö ¸øÇϹǷΠ¿©·¯ °¡Áö º´ÀûÀÎ Çö»óÀÌ »ý±ä´Ù. ½ÉÀ嵿¸ÆÀÌ Á¼¾ÆÁö´Â µ¥¿¡´Â ¿©·¯ °¡Áö ¿øÀÎÀÌ ÀÖÀ» ¼ö°¡ ÀÖÀ¸³ª ÁÖ·Î ½ÉÀ嵿¸ÆÀÇ µ¿¸Æ°æÈÁõ¿¡ ÀÇÇÑ´Ù. µ¿¸Æ°æÈÁõÀ̶õ µ¿¸ÆÀÇ ³»Ãþ¿¡ Áö¹æ°ú ÄÝ·¹½ºÅ×·Ñ·Î ÀÌ·ç¾îÁø Á×Á¾(atheroma)°¡ »ý±â´Â ÁúȯÀ¸·Î Á×Á¾ÀÌ »ý±ä µ¿¸ÆÀº Á×Á¾ÀÌ Ç÷°üÀÇ ³»ºÎ·Î µ¹ÃâÇÏ°Ô µÇ¾î¼ Ç÷°üÀÇ ³»°æÀÌ ÀÛ¾ÆÁö°Ô µÈ´Ù. ½ÉÀ嵿¸Æº´Àº ±× Á¤µµ¿¡ µû¶ó¼ Çù½ÉÁõ(angina pectoris)¿Í ½É±Ù°æ»öÁõ(myocardial infarction)À¸·Î ³ª´«´Ù. Çù½ÉÁõÀº ½ÉÀ嵿¸ÆÀÇ ºÎºÐÀû Æó¼â¿¡ ÀÇÇØ¼ Æò»ó½Ã¿¡´Â Áõ»óÀÌ ¾øÁö¸¸ ½ÉÀåÀÌ ¸¹Àº Ȱµ¿À» ÇÒ °æ¿ì¿¡ ½ÉÀå¿¡ Çǰ¡ ÃæºÐÇÑ ¸¸Å °ø±ÞÀÌ µÇÁö ¾Ê¾Æ¼ »ý±â´Â Áúº´À¸·Î Æò»ó½Ã¿¡ ½¯ °æ¿ì¿¡´Â ¾Æ¹« Áõ»óÀÌ ¾øÁö¸¸ ¿îµ¿À̳ª °ú½Ä µîÀÇ ¿øÀÎÀ¸·Î ½ÉÀåÀÌ ¸¹Àº ¿îµ¿À» ÇÒ °æ¿ì¿¡ ½ÉÀå¿¡ °ø±ÞµÇ´Â Ç÷¾×ÀÇ ¾çÀÌ ¸ðÀÚ¶ó¼ Áõ»ó(´ë°³ °¡½¿ºÎÀ§¿¡ Áã¾îÂ¥´Â µíÇÑ ÅëÁõ)ÀÌ »ý±ä´Ù. ½É±Ù°æ»öÁõÀ̶õ ½ÉÀ嵿¸ÆÀÇ ¿ÏÀüÆó¼â¿¡ ÀÇÇØ¼ ½ÉÀåÀÇ ±ÙÀ°ÀÌ Ç÷¾×À» ÀüÇô °ø±Þ¹ÞÁö ¸øÇؼ ½ÉÀåÀÇ ±ÙÀ°ÀÌ ½â´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. |
||
| ¿µ¹® | heart disease | ÇÑ±Û | ½ÉÀ庴 |
|---|---|---|---|
| ¼³¸í | ¼øÈ¯±â Áúȯ Áß ½ÉÀåÀÇ º´. ÀϹÝÀûÀ¸·Î ½ÉÀåÇ÷°üÀ̳ª ½ÉÀåÀÇ º´µµ Æ÷ÇԵȴÙ. º´ÅÍÀÇ ºÎÀ§¿¡ ÀÇÇÑ º´¸®ÇغÎÇÐÀû ºÐ·ù¿Í º´Àο¡ ÀÇÇÑ ºÐ·ù°¡ ÀÖ´Ù. ÀüÀÚ´Â ¼ö ½Ê ³â ÀüºÎÅÍ ¾²¿©Á® ¿ÔÀ¸³ª ±Ù³â¿¡ ¿Í¼ º»ÁúÀûÀÎ ¿øÀοä¹ýÀÌ °¡´ÉÇÏ°Ô µÈ ÀÌÈÄ´Â ÈÄÀÚÀÇ ºÐ·ù°¡ ÀÇÀǰ¡ ÀÖ¾î¼ ¸¹ÀÌ ¾²ÀÌ°Ô µÇ¾ú´Ù. º´ÅÍ ºÎÀ§·Î´Â ½É³»¸·(ÆÇ¸·)-½ÉÀå±Ù-½ÉÀ帷, ±× ¹ÛÀÇ °ÍÀ» µé ¼ö ÀÖÀ¸¸ç, °¢°¢ ½É³»¸·¿°-½ÉÀåÆÇ¸·Áõ-½É±Ù¿°-½É±Ù°æ»ö-½ÉÀ帷¿°-¼±Ãµ¼º ½ÉÀ庴(½ÉÀå±âÇü) µîÀÌÆ÷ÇԵȴÙ. º´Àκ°¿¡¼´Â ½ÉÀå±âÇüÀ» ºñ·ÔÇÏ¿© ·ù¸¶Ä¡½º ½ÉÀ庴-¸Åµ¶¼º ½ÉÀ庴-°íÇ÷¾Ð¼º ½ÉÀ庴-½ÉÀ嵿¸Æ°æÈ¼º ½ÉÀ庴-Æó¼º½ÉÀå-¼¼±Õ¼º ½É³»¸·¿°-½ÉÀå½Å°æÁõ µîÀ¸·Î ³ª´©¾îÁö¸ç, ºÎÁ¤¸ÆÀ̳ª ¹æ½ÇÂ÷´Ü µîÀÇ ÀÚ±ØÀüµµ°èÀÇ Àå¾Ö¿¡ ÀÇÇÑ °Íµµ Áõ¼¼ÀÇ Çϳª·Î º¼ ¼ö ÀÖ´Ù. ½ÉÀ庴Àº ÀÚ°¢ÀûÀ¸·Î´Â ¹«Áõ¼¼ÀÎ °Í¿¡¼ºÎÅÍ ½ÉÀå±â´É»ó½Ç·Î È£Èí°ï¶õ±îÁö ÀÖ´Ù. |
||
| CDC | calculated date of confinement; cancer diagnosis center; capillary diffusion capacity; cell division... |
|---|---|
| AID | acquired immunodeficiency disease; acute infectious disease; acute ionization detector; Agency for I... |
| IPA | immunoperoxidase assay; incontinentia pigmenti achromians; independent physician or practice associa... |
| ICD | 1) International (statistical) Classification of Diseases, (injuries & causes of death)<... |
| ICCS | International Classification of Clinical Services |
| ICIDH | International Classification of Impairments Disabilities and Handicaps |
|---|---|
| I.C.P.C. | International Classification of Primary Care |
| ICSD | International Classification of Sleep Disorders |
| ICDDR, B | International Centre for Diarrhoeal Disease Research, Bangladesh |
| IUATLD | International Union Against Tuberculosis and Lung Disease |
| multiaxial classification | A procedure used in DSM-III-R for diagnosing patients on five axes: 1) psychiatric syndrome present; 2) patient's history of personality and developmental disorders; 3) possible nonmental medical disorders; 4) severity of psychosocial stressors; 5) highest level of adaptive functioning in the past year. (05 Mar 2000) |
|---|---|
| portal hypertension: classification | <radiology> Presinusoidal, extrahepatic: portal vein obstruction (extrinsic compression, phlebitis, OC, coagulopathy, tumour invasion, pancreatitis, neonatal omphalitis), dynamic: traumatic/neoplastic arterioportal fistula, segmental portal hypertension: splenic/superior mesenteric vein occlusion, intrahepatic (obstruction of portal venules): congenital hepatic fibrosis, primary biliary cirrhosis, sarcoid, myelofibrosis, schistosomiasis, idiopathic noncirrhotic fibrosis, Wilson disease, reticuloendotheliosis, Felty syndrome, chronic malaria, toxic fibrosis (arsenic, copper, PVC vapors) sinusoidal, cirrhosis, sclerosing cholangitis postsinusoidal, Budd-Chiari syndrome, constrictive pericarditis, congestive heart failure (12 Dec 1998) |
| Cummer's classification | A listing of several types of removable partial dentures in accordance with the distribution of direct retainers. (05 Mar 2000) |
| Salter-Harris classification of epiphysial plate injuries | The classification of epiphysial plate injuries into five groups (I to V), according to the pattern of damage to epiphysis, physis, and/or metaphysis; the classification correlates with different prognoses regarding the effects of the injury on subsequent growth and subsequent deformity of the epiphysis. (05 Mar 2000) |
| horizontal classification | <zoology> Classification which stresses grouping together taxa in a similar stage of evolution, rather than location on the same phyletic line. See: Vertical classification. (09 Jan 1998) |
| natural classification | <zoology> Classification based on inferences concerning the phylogenetic relationships of animals. (09 Jan 1998) |
| New York Heart Association classification | A functional classification to assess cardiovascular disability. Class I: patients with cardiac disease without limitation of physical activity. Ordinary activity does not cause symptoms. Class II: patients with cardiac disease with slight limitation of activity; comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea or angina. Class III: patients with cardiac disease producing marked limitation of activity: comfortable at rest. Less than ordinary physical activity causes symptoms. Class IV: patients with cardiac disease resulting in inability to carry on any physical activity without discomfort. Symptoms may be present even at rest. (05 Mar 2000) |
| DeBakey's classification | Consists of three types: Type I extends into the transverse arch and distal aorta and type II is confined to the ascending aorta. Type III dissections begin in the descending aorta, with type IIIA extending toward the diaphragm and type IIIB extending below it. (05 Mar 2000) |
| Denver classification | A system of nomenclature for human mitotic chromosomes, based on length and position of the centromere. Origin: Denver,, Colourado, where agreed upon (05 Mar 2000) |
| Dukes' classification | A classification of the extent of operable adenocarcinoma of the colon or rectum commonly modified as follows: A (Duke's A), confined to the mucosa; B1, into the muscularis mucosae; B2, through the muscularis mucosae; C1, limited to the bowel wall, with nodal metastases; C2, through the bowel wall, with nodal metastases. (05 Mar 2000) |
| Tessier classification | An anatomical classification of facial, craniofacial, and laterofacial clefts that utilises the orbit as the primary structure for reference. Fifteen locations for clefts are differentiated. (05 Mar 2000) |
| E classification | <biochemistry> Classification of enzymes based on the recommendations of the Committee on Enzyme Nomenclature of the International Union of Biochemistry. The first number indicates the broad type of enzyme (1 = oxidoreductase, 2 = transferase, 3 = hydrolase, 4 = lyase, 5 = isomerase, 6 = ligase (synthetase)). The second and third numbers indicate subsidiary groupings and the last number, which is unique, is assigned arbitrarily in numerical order by the Committee. (08 Mar 2000) |
| TNM classification | TNM classification provides a system for staging the occurrence of cancer., T refers to the primary tumour and is categorised as being 1-4 and a-d depending upon site, size and spread, N refers to the lymph nodes and they are categorised as being X,0, 1, 2, or 3 depending upon if any, some or all are involved metastasis, and M to the presence or absence of distant metasteses. Refer Staging. (16 Dec 1997) |
| Jansky's classification | The classification of human blood groups now designated O, A, B, and AB. (05 Mar 2000) |
| FAB classification | <haematology> The classification of acute myeloid leukaemia on the basis of bone marrow and peripheral blood features. M0: Acute myeloid leukaemia with minimal evidence of myeloid differentiation. M1: Acute myeloblastic leukaemia. M2: Acute myeloblastic leukaemia with differentiation. M3: Acute promyelocytic leukaemia. M4: Acute myelomonocytic leukaemia. M5: Acute monocytic leukaemia. M6: Acute erythroleukaemia. M7: Acute megakaryocytic leukaemia. Acronym: FAB (07 Apr 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|